Clinical Trials Browser

Interventional × Lymphatic Metastasis × Gynecologic × Clear all

Lymphatic Metastasis, Vulvar Neoplasms

NCT07200466 2025-12-17

ENDORISK-I

Phase NA Recruiting

735 enrolled

Gynecologic

Lymphatic Metastasis, Endometrial Neoplasms

NCT06476639 2025-11-28

ANVU

Phase 3 Not yet recruiting

640 enrolled

Gynecologic

Lymphatic Metastasis, Vulvar Neoplasms

NCT05236686 2025-11-19

Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer

Phase NA Recruiting

94 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Lymphatic Metastasis, Ovarian Neoplasms

NCT03366051 2024-07-30

ALICE

Phase NA Recruiting

178 enrolled

Gynecologic

Lymphatic Metastasis, Endometrial Neoplasms

NCT06273501 2024-02-22

POSVUC

Phase NA Unknown

20 enrolled

Gynecologic

Lymphatic Metastasis, Vulvar Neoplasms

NCT05076942 2023-08-01

GROINSS-VIII

Phase 2 Recruiting

157 enrolled

Gynecologic

Lymphatic Metastasis, Vulvar Neoplasms

NCT05504642 2023-04-18

CERAD-IMMUNE

Phase 2 Withdrawn

Gynecologic

Uterine Cervical Neoplasms, Lymphatic Metastasis

NCT05375526 2022-05-16

Magtrial: Magtrace® as Tracer for Sentinel Lymph Node Detection in Early Stage Epithelial Ovarian Cancer

Phase NA Unknown

10 enrolled

Gynecologic

Lymphatic Metastasis, Ovarian Neoplasms

Clinical Trials

NODE

ENDORISK-I

ANVU

Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer

ALICE

POSVUC

GROINSS-VIII

CERAD-IMMUNE

Magtrial: Magtrace® as Tracer for Sentinel Lymph Node Detection in Early Stage Epithelial Ovarian Cancer